What is Zacks Research’s Forecast for THC Q4 Earnings?

Tenet Healthcare Corporation (NYSE:THC) – Research analysts at Zacks Research dropped their Q4 2027 earnings estimates for Tenet Healthcare in a report issued on Friday, October 16th. Zacks Research analyst Team now expects that the company will post earnings per share of $5.12 for the quarter, down from their prior forecast of $5.13. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $21.04 per share.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the previous year, the business earned $4.02 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS.

A number of other analysts have also recently weighed in on THC. Royal Bank Of Canada upped their price target on Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a report on Friday, October 2nd. Leerink Partners restated an “outperform” rating and issued a $309.00 target price on shares of Tenet Healthcare in a research note on Friday, September 18th. TD Cowen boosted their target price on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Finally, UBS Group upped their target price on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $278.45.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $266.58 on Monday. The business has a 50 day simple moving average of $264.48 and a 200 day simple moving average of $219.84. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company has a market capitalization of $21.46 billion, a PE ratio of 10.28, a price-to-earnings-growth ratio of 1.02 and a beta of 1.20. Tenet Healthcare has a one year low of $157.58 and a one year high of $283.05.

Institutional Trading of Tenet Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in THC. Manning & Napier Advisors LLC bought a new position in Tenet Healthcare in the 2nd quarter worth approximately $168,761,000. Bank of New York Mellon Corp acquired a new position in Tenet Healthcare during the 2nd quarter worth $106,342,000. Hsbc Holdings PLC boosted its position in Tenet Healthcare by 3,478.7% in the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after buying an additional 258,956 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in Tenet Healthcare by 57.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock valued at $126,757,000 after buying an additional 244,901 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Tenet Healthcare by 535.9% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 127,677 shares of the company’s stock valued at $24,094,000 after buying an additional 107,600 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Lisa Foo sold 24,000 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the sale, the executive vice president directly owned 8,053 shares in the company, valued at $2,144,674.96. This represents a 74.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Saumya Sutaria sold 50,000 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer directly owned 483,564 shares of the company’s stock, valued at $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 131,199 shares of company stock worth $35,065,587 over the last ninety days. 0.97% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.